StockData
Polaryx Therapeutics, Inc. logo

Polaryx Therapeutics, Inc. (PLYX) stock

PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.61+0.01 (+0.63%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

Polaryx Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Polaryx Therapeutics's market cap was $97.20M on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$97.20M–

More Polaryx Therapeutics figures

See a number that looks wrong?